Navigation Links
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
Date:8/5/2009

.5 million as compared to $7.4 million in the same period in 2008.

Amicus recorded revenue during the second quarter of 2009 representing two different revenue streams from the Shire agreement. Upon signing the agreement, Amicus received an upfront payment of $50 million that will be recognized as revenue on a straight-line basis over 18 years from the date of the agreement. In the second quarter of 2009, Amicus recognized $0.7 million of the Shire upfront payment and $4.7 million of research revenue on reimbursed research and development costs.

The differences between U.S. GAAP and non U.S. GAAP financial results are itemized in Tables 2 and 3 and are primarily due to pre-tax stock compensation expense.

Use of Non-GAAP Financial Measures

Amicus' "non-GAAP net loss" and "non-GAAP diluted net loss per common share" financial measures are defined as reported, or GAAP, net loss and diluted net loss per common share excluding certain items further discussed below. Amicus' management uses these non-GAAP financial measures to establish financial goals and to gain an understanding of the comparative financial performance of Amicus from year to year and quarter to quarter. Accordingly, Amicus believes investors' understanding of Amicus' financial performance is enhanced as a result of disclosing these non-GAAP financial measures. Non-GAAP net loss and diluted net loss per common share should not be viewed in isolation or as a substitute for reported, or GAAP net loss and diluted net loss per common share.

(1) Stock option expense -- Non-GAAP net loss and diluted net loss per common share exclude the impact of the stock option expense recorded in accordance with SFAS No. 123R. Amicus believes that excluding the impact of expensing stock options better reflects the recurring economic characteristics of its business.

Conference Call and Webcast'/>"/>

SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... MUNDELEIN, Ill. , May 23, 2013 ... company providing value-added ingredients to a variety of industries, ... participated in a panel discussion at this year,s National ... May 20-21, 2013, on behalf of the Research Chefs ... Development for Restaurants: The Good, the Bad and the ...
(Date:5/23/2013)... Toronto, Canada (PRWEB) May 23, 2013 ... subjects, it is critical to adhere to principles ... protection (HSP). , Esteemed speaker Dr. Jeremy Lim, ... the audience: , ,     Understand the ... Clinical Practice (GCP) and additional regulations for the ...
(Date:5/23/2013)... May 23, 2013 Bed bugs ... university had already confirmed it. Meanwhile, My Cleaning Products offered ... bug victims fight the pests without using harmful chemical elements. ... May 15, 2013, the affected building was actually a ... infested was said made on May 13 and bed bug ...
(Date:5/22/2013)... Industry leaders from around the ... Oak Ridge National Laboratory’s Biosurveillance Symposium ... the Hilton Alexandria Mark Center. Held in conjunction ... conference on June 18 - 19. , Join ... Elements, Applied Research Associates, ARA, AttaGene, Battelle, Benedictine ...
Breaking Biology Technology:Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 2Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 3Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 4Biodetection Technologies 2013 and Oak Ridge National Lab’s Biosurveillance Symposium to Bring Together Leading Organizations in Alexandria, VA from June 17-19, 2013 5
... Inc. (IVT),a vaccine development company, unveiled today its ... to increase the efficacy and,strength of vaccines. IVT ... "The results from our preclinical studies demonstrate ... remarked Marc Mansour, vice,president of research and development ...
... Biophysicist Brings Expertise in Single Molecule Fluorescence and ... Nanoscale ... Inc., a developer,of breakthrough nanoscale whole genome imaging platforms ... appointment of noted biophysicist Paul R. Selvin, Ph.D., to ...
... and Storage Systems Fuel Faster Time to Discovery for ... Researchers Seeking Causes and Cures of Disease, BOSTON, April ... As scientists seek to accelerate sequencing,genomes of varied arrays of ... determine causes and cures of diseases that plague mankind,breakthrough technology ...
Cached Biology Technology:ImmunoVaccine Technologies Patents DepoVax(TM) Vaccine Platform 2BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board 2BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advisory Board 3SGI Breakthrough Technology Empowers Genome Center Research Around the World 2SGI Breakthrough Technology Empowers Genome Center Research Around the World 3SGI Breakthrough Technology Empowers Genome Center Research Around the World 4SGI Breakthrough Technology Empowers Genome Center Research Around the World 5
(Date:5/22/2013)... CITY, May 22, 2013 U.S. Forest Service scientists ... that, with funding from the TKF Foundation, will examine ... communities and individuals recover from tragedy. , The TKF ... of six projects selected for grant funding. In addition ... sacred spaces in recovery and resiliency, the 3-year, $585,000 ...
(Date:5/22/2013)... working to improve durability in fuel cell powered ... have discovered links between electrode degradation processes and ... the effects of electrode degradation stressors in the ... lifetime. , The findings of the study, led ... latest in a long-term study at Burnaby-based Ballard ...
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Tests lead to doubling of fuel cell life 2
... MD, received the 2010 Recognition Award for Scientific Accomplishments ... Monday, May 17. , Dr. Downey, Executive Vice President ... Immunology at National Jewish Health, has over 190 publications ... authors more than 5,000 times, putting him in the ...
... - (May 17, 2010) In the Opening Session ... National Biotechnology Conference, AAPS President Danny D. Shen, Ph.D., ... contributions to the pharmaceutical sciences: Excellence in ... , From ANP Technologies, Inc.: Ray Yin; Yli ...
... Ind. - Using NASA satellite data and Google Earth, ... North Korea has been logging in what is designated ... Shao, professor of geo-eco-informatics, studies the Mount Paekdu Biosphere ... many researchers are unable to visit North Korea, Shao ...
Cached Biology News:Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments 2AAPS announces 2010 NBC award winners 2NASA, Google data show North Korea logging in protected area 2
Mouse monoclonal antibody raised against a partial recombinant L3MBTL2. NCBI Entrez Gene ID = L3MBTL2...
Mouse monoclonal antibody raised against a partial recombinant ALAS2. NCBI Entrez Gene ID = ALAS2...
Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...
96-well format (For processing samples on microplate-size MALDI target plates such as those from Bruker, Shimadzu, Thermo, and PerkinElmer) Packaging: 2 / pack...
Biology Products: